E72.548 可计费的具体编码 Other secondary hyperoxaluria
ICD-10-CM E72.548 identifies “Other secondary hyperoxaluria” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 4: Endocrine, nutritional and metabolic diseases
编码说明
无额外说明。
上级编码说明
章节 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70-E88 · Metabolic disorders (E70-E88)
Excludes 15
Excludes 21
Ehlers-Danlos syndromes (Q79.6-)
E72 · Other disorders of amino-acid metabolism
E72.54 · Secondary hyperoxaluria
Excludes 11
primary hyperoxaluria (E72.53-)
官方索引引用
官方索引引用 (1)
官方转换历史
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
以前的归类: R82.992
历史
编码历史
最近记录的变更 · FY2026
生效日期
- 新增
Other secondary hyperoxaluria
可用于账单的诊断编码
CDC/NCHS · FY2026所有版本 (3)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2026 | 2025-10-01 | 新增 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
此条目是所选版本中的完整编码。 参考核验不能确定临床适用性,也不保证报销。